# Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use

> **NCT04439396** · PHASE1 · COMPLETED · sponsor: **Carilion Clinic** · enrollment: 183 (actual)

## Conditions studied

- Breast Reduction
- Breast Reconstruction

## Interventions

- **DRUG:** Ketorolac Tromethamine
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT04439396
- **Lead sponsor:** Carilion Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-22
- **Primary completion:** 2023-01-30
- **Final completion:** 2023-01-30
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04439396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04439396, "Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04439396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*